Zobrazeno 1 - 10
of 42
pro vyhledávání: '"Harlan Krumholz"'
Autor:
Ho-Joon Lee, Lee H. Schwamm, Lauren H. Sansing, Hooman Kamel, Adam de Havenon, Ashby C. Turner, Kevin N. Sheth, Smita Krishnaswamy, Cynthia Brandt, Hongyu Zhao, Harlan Krumholz, Richa Sharma
Publikováno v:
npj Digital Medicine, Vol 7, Iss 1, Pp 1-22 (2024)
Abstract Determining acute ischemic stroke (AIS) etiology is fundamental to secondary stroke prevention efforts but can be diagnostically challenging. We trained and validated an automated classification tool, StrokeClassifier, using electronic healt
Externí odkaz:
https://doaj.org/article/783bc7ef231042f9a5f3a11d5af6d3ea
Autor:
Christina Yap, Olalekan Lee Aiyegbusi, Emily Alger, Ethan Basch, Jill Bell, Vishal Bhatnagar, David Cella, Philip Collis, Amylou C. Dueck, Alexandra Gilbert, Ari Gnanasakthy, Alastair Greystoke, Aaron R. Hansen, Paul Kamudoni, Olga Kholmanskikh, Bellinda L. King-Kallimanis, Harlan Krumholz, Anna Minchom, Daniel O'Connor, Joan Petrie, Claire Piccinin, Khadija Rerhou Rantell, Saaeha Rauz, Ameeta Retzer, Steven Rizk, Lynne Wagner, Maxime Sasseville, Lesley K. Seymour, Harald A. Weber, Roger Wilson, Melanie Calvert, John Devin Peipert
Publikováno v:
EClinicalMedicine, Vol 76, Iss , Pp 102838- (2024)
Summary: Early phase clinical trials provide an initial evaluation of therapies’ risks and benefits to patients, including safety and tolerability, which typically relies on reporting outcomes by investigator and laboratory assessments. Use of pati
Externí odkaz:
https://doaj.org/article/67c77703c1de4dd99159ee45db094c8f
Autor:
Jenerius A. Aminawung, Lisa B. Puglisi, Brita Roy, Nadine Horton, Johanna E. Elumn, Hsiu‐Ju Lin, Kirsten Bibbins‐Domingo, Harlan Krumholz, Emily A. Wang
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 13, Iss 18 (2024)
Background Incarceration is a social determinant of cardiovascular health but is rarely addressed in clinical settings or public health prevention efforts. People who have been incarcerated are more likely to develop cardiovascular disease (CVD) at y
Externí odkaz:
https://doaj.org/article/060fef792b6e4b638bc096af00241fea
Autor:
Adam de Havenon, Walter N Kernan, Harlan Krumholz, Kevin N Sheth, Guido J Falcone, Richa Sharma, Seyedmehdi Payabvash, Cyprien Rivier, Rachel Forman
Publikováno v:
BMJ Neurology Open, Vol 6, Iss 1 (2024)
Background Vascular brain injury (VBI) may be an under-recognised contributor to mobility impairment. We examined associations between MRI VBI biomarkers and impaired mobility.Methods We separately analysed Atherosclerosis Risk in Communities (ARIC)
Externí odkaz:
https://doaj.org/article/23d0a28248dc42b2aa498eb841139195
Publikováno v:
PLoS ONE, Vol 18, Iss 1, p e0279905 (2023)
IntroductionOver the past two decades, percutaneous coronary intervention (PCI) capacity has increased while coronary artery disease has decreased, potentially lowering per-hospital PCI volumes, which is associated with less favorable patient outcome
Externí odkaz:
https://doaj.org/article/39ac7bf7693f4ad0a227ce6cc7aa591e
Autor:
Jianlei Gu, Harlan Krumholz, Hongyi Wang, Zhiying Zhang, Ningling Sun, Luyan Wang, Zheng J Ma, Zheng Lian
Publikováno v:
Open Heart, Vol 8, Iss 2 (2021)
Externí odkaz:
https://doaj.org/article/07aee1d34f844f8f8f4f14825b986123
Autor:
Arash A. Nargesi, Gini P. Jeyashanmugaraja, Nihar Desai, Kasia Lipska, Harlan Krumholz, Rohan Khera
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 10, Iss 13 (2021)
Background SGLT‐2 (sodium glucose transporter‐2) inhibitors and GLP‐1RAs (glucagon‐like peptide‐1 receptor agonists) effectively lowered cardiovascular risk in large clinical trials for patients with type 2 diabetes mellitus at high risk fo
Externí odkaz:
https://doaj.org/article/7512335068224f3d8cceea14f1c488c1
Autor:
Daisy Massey, Chenxi Huang, Yuan Lu, Alina Cohen, Yahel Oren, Tali Moed, Pini Matzner, Shiwani Mahajan, César Caraballo, Navin Kumar, Yuchen Xue, Qinglan Ding, Rachel Dreyer, Brita Roy, Harlan Krumholz
Publikováno v:
Journal of Medical Internet Research, Vol 23, Iss 6, p e26655 (2021)
BackgroundCOVID-19 has continued to spread in the United States and globally. Closely monitoring public engagement and perceptions of COVID-19 and preventive measures using social media data could provide important information for understanding the p
Externí odkaz:
https://doaj.org/article/c07dae974d04485192f033a93f3a1b16
Autor:
Connor A. Emdin, Amit V. Khera, Mark Chaffin, Derek Klarin, Pradeep Natarajan, Krishna Aragam, Mary Haas, Alexander Bick, Seyedeh M. Zekavat, Akihiro Nomura, Diego Ardissino, James G. Wilson, Heribert Schunkert, Ruth McPherson, Hugh Watkins, Roberto Elosua, Matthew J. Bown, Nilesh J. Samani, Usman Baber, Jeanette Erdmann, Namrata Gupta, John Danesh, Daniel Chasman, Paul Ridker, Joshua Denny, Lisa Bastarache, Judith H. Lichtman, Gail D’Onofrio, Jennifer Mattera, John A. Spertus, Wayne H.-H. Sheu, Kent D. Taylor, Bruce M. Psaty, Stephen S. Rich, Wendy Post, Jerome I. Rotter, Yii-Der Ida Chen, Harlan Krumholz, Danish Saleheen, Stacey Gabriel, Sekar Kathiresan
Publikováno v:
Nature Communications, Vol 9, Iss 1, Pp 1-8 (2018)
Examination of predicted loss-of-function (pLOF) genetic variants allows direct identification of genes with therapeutic potential. Here, Emdin et al. perform association analysis for 3759 pLOF variants with 24 traits and highlight protective variant
Externí odkaz:
https://doaj.org/article/5b782df960c64245a2f0b6bdfadd7745
Autor:
Stephen Kaptoge, Lisa Pennells, Dirk De Bacquer, Marie Therese Cooney, Maryam Kavousi, Gretchen Stevens, Leanne Margaret Riley, Stefan Savin, Taskeen Khan, Servet Altay, Philippe Amouyel, Gerd Assmann, Steven Bell, Yoav Ben-Shlomo, Lisa Berkman, Joline W Beulens, Cecilia Björkelund, Michael Blaha, Dan G Blazer, Thomas Bolton, Ruth Bonita Beaglehole, Hermann Brenner, Eric J Brunner, Edoardo Casiglia, Parinya Chamnan, Yeun-Hyang Choi, Rajiv Chowdry, Sean Coady, Carlos J Crespo, Mary Cushman, Gilles R Dagenais, Ralph B D'Agostino Sr, Makoto Daimon, Karina W Davidson, Gunnar Engström, Ian Ford, John Gallacher, Ron T Gansevoort, Thomas Andrew Gaziano, Simona Giampaoli, Greg Grandits, Sameline Grimsgaard, Diederick E Grobbee, Vilmundur Gudnason, Qi Guo, Hanna Tolonen, Steve Humphries, Hiroyasu Iso, J Wouter Jukema, Jussi Kauhanen, Andre Pascal Kengne, Davood Khalili, Wolfgang Koenig, Daan Kromhout, Harlan Krumholz, TH Lam, Gail Laughlin, Alejandro Marín Ibañez, Tom W Meade, Karel G M Moons, Paul J Nietert, Toshiharu Ninomiya, Børge G Nordestgaard, Christopher O'Donnell, Luigi Palmieri, Anushka Patel, Pablo Perel, Jackie F Price, Rui Providencia, Paul M Ridker, Beatriz Rodriguez, Annika Rosengren, Ronan Roussel, Masaru Sakurai, Veikko Salomaa, Shinichi Sato, Ben Schöttker, Nawar Shara, Jonathan E Shaw, Hee-Choon Shin, Leon A Simons, Eleni Sofianopoulou, Johan Sundström, Henry Völzke, Robert B Wallace, Nicholas J Wareham, Peter Willeit, David Wood, Angela Wood, Dong Zhao, Mark Woodward, Goodarz Danaei, Gregory Roth, Shanthi Mendis, Oyere Onuma, Cherian Varghese, Majid Ezzati, Ian Graham, Rod Jackson, John Danesh, Emanuele Di Angelantonio
Publikováno v:
The Lancet Global Health, Vol 7, Iss 10, Pp e1332-e1345 (2019)
Summary: Background: To help adapt cardiovascular disease risk prediction approaches to low-income and middle-income countries, WHO has convened an effort to develop, evaluate, and illustrate revised risk models. Here, we report the derivation, valid
Externí odkaz:
https://doaj.org/article/cbe6b4445261496287e2ed04c8f32089